NIH Guide: Weekly Index for September 4, 2020

Funding Opportunities

• Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)
  (PAR-20-302)
  National Cancer Institute
  Office of Disease Prevention
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): November 12, 2020; thereafter, Standard dates apply.
• Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional)
  (PAR-20-303)
  National Cancer Institute
  Office of Disease Prevention
  Application Receipt Date(s): November 12, 2020; thereafter, Standard dates apply.
• HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
  (PAR-21-024)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
• NIH Blueprint for Neuroscience Research: Functional Neural Circuits of Interoception (R01, Clinical Trial Not Allowed)
  (RFA-AT-21-003)
  National Center for Complementary and Integrative Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Institute of Biomedical Imaging and Bioengineering
  Office of Behavioral and Social Sciences Research
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): December 18, 2020
• Genomic Data Analysis Network: Genomic Data Analysis Center (U24 Clinical Trial Not Allowed)
  (RFA-CA-20-053)
  National Cancer Institute
  Application Receipt Date(s): November 12, 2020 No late applications will be accepted for this FOA.
• Toward ElucidAting MechanismS Contributing to HIV Reservoirs in NIDDK-relevant Tissues (Cure TEAMS) (R01 Clinical Trial Optional)
  (RFA-DK-20-023)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
• Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
  (RFA-ES-20-014)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): February 15, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trial Not Allowed)
  (RFA-EY-20-001)
  National Eye Institute
  Application Receipt Date(s): January 15, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
• Centers to Advance Research in Endometriosis (CARE) (P01 Clinical Trial Not Allowed)
  (RFA-HD-21-002)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Cancer Institute
  National Institute of Environmental Health Sciences
  Office of Research on Women's Health
  Application Receipt Date(s): November 30, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.